Neuronetics, Inc. (STIM) vs Veraxa Biotech Holding AG (VRXA)

A side-by-side comparison of Neuronetics, Inc. and Veraxa Biotech Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

STIM

Neuronetics, Inc.

$154M

$2.22HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

VRXA

Veraxa Biotech Holding AG

$148M

$1.05HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT

Total return — STIM vs VRXA

growth of $100 · dividends reinvested · last 1y

STIM +73.2% (+73.2%/yr)VRXA -90.8% (-90.8%/yr)STIM compounded faster over this window

Log scale — wide-divergence pair

STIM VRXA

Metrics side by side

Total return (annualized)

Metric	STIM	VRXA
Total return (1Y)	-22.71%	N/A
Total return CAGR (3Y)	24.49%	N/A
Total return CAGR (5Y)	-19.46%	N/A

VRXA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full STIM analysis Full VRXA analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.